Article Text

See original article:

PDF

Correction

Statistics from Altmetric.com

Keystone EC, Wang MM, Layton M, et al. Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine. Ann Rheum Dis 2010;69:1630–5. This was published in the print issue with the incorrect doi 10.1136/ annrheumdis-2011-143578. The correct doi is 10.1136/ard.2010.143578 because this is the doi it was originally published with online first.

View Abstract

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Correction
    BMJ Publishing Group Ltd and European League Against Rheumatism
  • Miscellaneous
    BMJ Publishing Group Ltd and European League Against Rheumatism